Mirae Asset Global ETFs Holdings
CPRX

Mirae Asset Global ETFs Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
63,835
+1,053
+2% +$31.1K ﹤0.01% 1244
2026
Q1 		$1.55M Buy
62,782
+14
+0% +$334 ﹤0.01% 1302
2025
Q4 		$1.46M Buy
62,768
+951
+2% +$21.2K ﹤0.01% 1316
2025
Q3 		$1.22M Sell
61,817
-6,371
-9% -$131K ﹤0.01% 1373
2025
Q2 		$1.48M Sell
68,188
-3,864
-5% -$91.2K ﹤0.01% 1249
2025
Q1 		$1.75M Buy
72,052
+3,800
+6% +$85.6K ﹤0.01% 1217
2024
Q4 		$1.43M Buy
68,252
+2,252
+3% +$48.4K ﹤0.01% 1351
2024
Q3 		$1.31M Buy
66,000
+2,071
+3% +$38.4K ﹤0.01% 1386
2024
Q2 		$987K Buy
+63,929
New +$995K ﹤0.01% 1459

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CPRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Catalyst Pharmaceutical (CPRX) stake by 1.7% in Q2 2026, buying an estimated $31.1K and bringing the position to 63,835 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Mirae Asset Global ETFs Holdings first reported a position in CPRX in Q2 2024 and has held it in 9 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 63,835 shares of Catalyst Pharmaceutical worth $2.01M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,053 Catalyst Pharmaceutical shares in Q2 2026, an estimated $31.1K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1244 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Catalyst Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.